Since 1995, the
European Commission, on the basis of an opinion prepared by the European Agency for the Evaluation of Medicinal Products (EMEA), has allowed certain medical products to be registered in the
European Community under a centralized procedure. These products may then be marketed directly in all member states without additional national registration in individual member states. European Blue List: European Drug Registrations is a compilation of essential parts of the European Public Assessment Reports (EPARs) issued for centrally authorized medicinal products for human and
veterinary use. This loose-leaf handbook also contains relevant regulations and directives that constitute…
